Hyperion Therapeutics Inc (NASDAQ:HPTX) Investor Alert: Acquisition Faces Investigation
April 07, 2015 at 06:00 AM EDT
San Diego, CA -- (ReleaseWire) -- 04/07/2015 -- An investigation on behalf of investors, who currently hold shares of Hyperion Therapeutics Inc (NASDAQ:HPTX), was announced concerning whether the takeover of Hyperion Therapeutics Inc by Horizon Pharma plc for $46.00 per share is unfair to NASDAQ:HPTX stockholders.